Effect of transplantation of allogeneic multipotent mesenchymal bone marrow stromal cells on regeneration of liver after extended hepatectomy (experimental study)

Cover Page

Cite item

Abstract

Multipotent mesenchymal stromal cells can be a drug for treatment of acute liver failure. The purpose of this study was to assess the effect of multipotent mesenchymal stromal cells on the proliferative, mitotic activity of hepatocytes and morphometric criteria for the regeneration of liver parenchyma after 68 % partial hepatectomy in rats. The number of mitosis, PCNA positive cells, diameter of nucleus of hepatocytes, size of hepatocytes, nuclear-cytoplasmic ratio (NCR), the area of hepatic lobules were evaluated on 1, 2, 4, 14 days after surgery. The results of the study showed that intravenous administration of allogeneic mesenchymal multipotent stromal cells from bone marrow after extended hepatectomy increase the number of proliferating hepatocytes (PCNA positive cells), but does not affect the number of mitoses, the diameter of the nucleus, the area of hepatocytes, NCR and hepatic lobules. Probably, at this time, regeneration proceeds primarily through an intracellular mechanism.

Full Text

Restricted Access

About the authors

V. S Rudakov

AA. Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency

Email: Rudakov_VC@list.ru

R. V Deev

N.I. Pavlov Ryazan Medical University

K. K Gubarev

AA. Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency

T. A Astrelina

AA. Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency

I. I Eremin

Central Clinical Hospital with Polyclinics of Administration of President of the Russian Federation

Yu. A Zhgutov

AA. Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency

E. I Onnitsev

S.M. Kirov Military Medical Academy

M. O Mavlikeev

Kazan (Volga region) Federal University

A. A Titova

Kazan (Volga region) Federal University

S. E Voskanyan

AA. Burnasyan Federal Medical Biophysical Center, Federal Medical Biological Agency

References

  1. Putignano A., Figorilli F., Alabsawy E. et. al. Long-term outcome in patients with acute liver failure. Liver Int. 2018; 10.1111/liv.13914.
  2. O’Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014; 60(3): 663-70.
  3. Watt K.D., Pedersen R.A., Kremers W.K. et al. Evolution of Causes and Risk Factors for Mortality Post Liver Transplant: Results of the NIDDK Long Term Follow-up Study. American Journal transplantation 2010; 10(6): 1420-7.
  4. Котенко К.В., Восканян С.Э., Еремин И.И. и др. Перспективы применения клеточных продуктов в хирургической гепатологии. Гепатогастроэнтерология 2011; 5-6: 208-16.
  5. Рудаков В.С., Восканян С.Э., Еремин И.И. и др. Применение мультипотентных мезенхимальных стромальных клеток в лечении острой печеночной недостаточности после обширной резекции печени в эксперименте. Гены и Клетки 2016; 11(4): 70-4.
  6. Рудаков В.С., Восканян С.Э., Еремин И.И. и др. Экспериментальные модели острой печеночной недостаточности. Российский медико-биологический вестник имени академика И.П. Павлова 2015; 4: 138-44.
  7. Sun X.E., Zhang X.Q., Liu M.M. Effect of bone marrow mesenchymal stem cells on the TGF-B1/Smad signaking pathway of hepatic stellate. Genetic and Molecular Research 2015; 14: 8744-54.
  8. Michalopoulos G.K., Marie C. Liver Regeneration. DeFrances Science 1997; 276: 60-6.
  9. Liu W., Song F., Ren L.N. et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. Cell. Mol. Med. 2015; 3: 511-20.
  10. Cen P., Chen J., Hu C. et al. Noninvasive in-vivo tracing and imagimg of transplanted stem cells for liver regeneration. Stem Cell Research & Therapy 2016; 7: 1-11.
  11. Akhan E., Tuncel D., Akcali K.C. Nanoparticle Labeling of Bone Marrow-Derived Rat Mesenchymal Stem Cells: Their Use in Differentiation and Tracking. Biomed. Res. Int. 2015; 19: 511-20.
  12. Газизов И.М., Калигин М.С., Андреева Д.И. и др. Изменения микроструктуры печени после частичной гепатэктомии у крыс. Гены и Клетки 2013; 8(3): 101-5.
  13. Liu T., Mu H., Shen Z. et al. Autologous adipose tissue-derived mesenchymal stem cells are involved in rat liver regeneration following repeat partial hepatectomy. Mol. Med. Rep. 2016; 13(3): 2053-9.
  14. Yu J., Yin S., Zhang W. et al. Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model. Stem Cell Research & Therapy 2013; 4: 1-9.
  15. Baretta G.A., Gama Filho O., Toderke E.L. et al. Effect of cyclosporine on liver regeneration in partial hepatectomized rats. Acta Cir. Bras. 2015; 30(1): 54-9.
  16. Biondo-Simöes M.L.P., Matias J.E.F., Montibeller G.R. et al. Effect of aging on liver regeneration in rats. Acta Cirurgica Brasileir 2006; 1(4): 197-202.
  17. D’Espressailles A., Dossi C., Intriago G. et al. Hormonal pretreatment preserves liver regenerative capacity and minimizes inflamation after partial hepatectomy. Annals of hepatology 2013; 12(6): 981-91.

Copyright (c) 2018 PJSC Human Stem Cells Institute



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 57156 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies